ABX CRO advanced pharmaceutical services Forschungsgesellschaft mbH

Offer

ABX-CRO as an independent full service CRO and image core lab was established in 2002 with headquarters in Dresden, Germany. Being closely linked in the past to the development of modern imaging and therapy, ABX-CRO has retained a strong focus in oncology, neuroscience, and imaging indications. Our interdisciplinary set-up with experts specialized in their field enables ABX-CRO to successfully implement all types of Phase I – III clinical trials, post-marketing Phase IV trials and pre-clinical experiments with or without imaging endpoints. Our current operations enable us to serve our customers on a global basis. Thanks to our special interdisciplinary approach ABX-CRO succesfully implements most unusual trials with the same reliability as standard protocols. ABX-CRO has a complete range of regularly updated SOPs and is ISO 9001 accredited.



ABX-CRO represents experience conducting complex clinical trials all over Europe. Among others, we conduct multidisciplinary, multinational, phase I dose-escalation trials with therapeutic radiopharmaceuticals. Previous experience includes projects with small molecules, biologicals, and cellular vaccines, in oncology, infectiology, nuclear medicine, and clinical neurophysiology.

Short description of the production/service program: Contract Research Organization (CRO) for preclinical and Phase I-III clinical trial development of new products for the biotechnology and pharmaceutical industries.

Major customers, markets and industries: Biotechnology and pharmaceutical companies



ABX-CRO is based in Germany with global clinical coverage through local cooperative offices in Australia, Japan, Switzerland and the US, a network of home based pharmaceutical research experts, CRAs and regulatory experts and cooperations with leading research institutions and (university) clinics in Europe, North America and Japan.

Trades